ArticleNPJ precision oncology2021

Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers.

Vincent Vuaroqueaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.